Exam (elaborations) NR 661
1. ADA Diagnostic Criteria for T2DM 2. ADA Diagnostic Criteria for IFG (pre-diabetics) 3. Intial Management 4. What is a reasonable A1C goal for a newly diagnosed patient with diabetes? 5. Treatment Goals 6. ADA treatment for IFG or A1C 5.7-6.4% 7. When to consider Metformin 8. ADA first line treatment Evidence Level A: 9. What is a contraindication for initiating metformin in a newly diagnosed patient with diabetes 10. A person who binges on metformin? 11. Metformin is often chose for 12. How much metformin expected to decrease A1C% in a patient who take moderate dose daily? 13. Exercise decreases A1C to 14. Metformin plus what other meds: 15. Sulfonylurea 16. DPP4 agents 17. TZDs 18. GLP-1 Agonists (injectable) 19. Mr. Jones is a active 60 y/o retired patient who was diagnosed with type 2 diabetes 6 months ago. what is the appropriate action today according to ADA? 20. What meds are safe when combined? 21. *Usually discontinue sulfonylureas, glitazones after initiating insulin 22. A1C 5.9%, newly diagnosed with IFG 23. 55 y/o female, intolerant of metformin, 24. 79 y/o male, A1C 8.9%, newly 25. 62 y/o female taking metformin, A1C 26. 27 y/o male, A1C 6.9%, newly 27. 62 y/o female who takes metformin, 28. 55 y/o female, takes metformin plus 29. Cashopenic 30. When should you consider insulin? 31. Insulin Type: Immediate 32. Regular 33. Mixed (rapid plus 34. NPH 35. Long Acting 36. Basal Insulin Formulations 37. Initiating Basal Insulin 38. Once you need better control... 39. Thyroid Stimulating Hormone 40. Common Signs and Symptoms:Hypothyroidism .......................................CONTINUED........................
Written for
- Institution
-
Chamberlain College Nursing
- Course
-
NR 661
Document information
- Uploaded on
- May 6, 2021
- Number of pages
- 5
- Written in
- 2020/2021
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
1 ada diagnostic criteria for t2dm 2 ada diagnostic criteria for ifg pre diabetics 3 intial management 4 what is a reasonable a1c goal for a newly diagnosed patient with diabetes 5 treatment g